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L-Serine plays a critical role as a building block for cell growth, and thus it is difficult to achieve the direct fermentation of 
L-serine from glucose. In this study, Corynebacterium glutamicum ATCC 13032 was engineered de novo by blocking and at-
tenuating the conversion of L-serine to pyruvate and glycine, releasing the feedback inhibition by L-serine to 
3-phosphoglycerate dehydrogenase (PGDH), in combination with the co-expression of 3-phosphoglycerate kinase (PGK) and 
feedback-resistant PGDH (PGDHr). The resulting strain, SER-8, exhibited a lower specific growth rate and significant differ-
ences in L-serine levels from Phase I to Phase V as determined for fed-batch fermentation. The intracellular L-serine pool 
reached (14.22±1.41) μmol gCDM1, which was higher than glycine pool, contrary to fermentation with the wild-type strain. 
Furthermore, metabolic flux analysis demonstrated that the over-expression of PGK directed the flux of the pentose phosphate 
pathway (PPP) towards the glycolysis pathway (EMP), and the expression of PGDHr improved the L-serine biosynthesis  
pathway. In addition, the flux from L-serine to glycine dropped by 24%, indicating that the deletion of the activator GlyR re-
sulted in down-regulation of serine hydroxymethyltransferase (SHMT) expression. Taken together, our findings imply that 
L-serine pool management is fundamental for sustaining the viability of C. glutamicum, and improvement of C1 units genera-
tion by introducing the glycine cleavage system (GCV) to degrade the excessive glycine is a promising target for L-serine pro-
duction in C. glutamicum. 
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The amino acid L-serine is one of the major components for 
nutritional growth and development of the central nervous 
system of mammals [1,2], but is also a predominant source 
of one-carbon (C1) units in de novo biosynthesis of purines, 
amino acids and thymidylate [35] as well as an intermedi-
ate for phospholipid biosynthesis [6] in a variety of organ-
isms. Given its critical role as a building block for cell 
growth, the bacterium Corynebacterium glutamicum, for 
example, has as much as 7.5% of its total glucose-originat- 
ing carbon flux distributed to L-serine biosynthesis [7]. In  
C. glutamicum, L-serine biosynthesis is initiated from the 
glycolytic intermediate 3-phosphoglycerare and carried 
through three sequential reactions catalyzed by 3-phospho- 
glycerate dehydrogenase (PGDH), 3-phosphoserine ami-
notransferase (PSAT) and 3-phosphoserine phosphatase 
(PSP), respectively. PGDH is the gene product of serA and 
catalyzes the oxidation of 3-phosphoglycerare to generate 
3-phosphohydroxypyruvate. PSAT is encoded by serC and 
catalyzes the transamination of 3-phosphohydroxypyruvate 
to yield 3-phosphoserine. 3-Phophoserine is then dephosp- 
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horylated to yield L-serine catalyzed by PSP, a gene product 
of serB (Figure 1). Among the three enzymes, PDGH is 
found to be sensitive to feedback inhibition by L-serine and 
only remains 60% activity in the presence of 10 mmol L1 
L-serine [8]. It has also been identified that the car-
boxy-terminal 197 amino acids of PGDH are responsible for 
the feedback inhibition by L-serine and its deletion has only 
a minimal effect on the enzyme activity [8].  
Catabolism of L-serine in C. glutamicum proceeds via 
pyruvate in the presence of glucose. This conversion reac-
tion is catalyzed by L-serine dehydratase (L-SerDH) encod-
ed by the gene sdaA [9]. L-Serine is also used to provide 
building blocks for amino acid biosynthesis including gly-
cine, cysteine and tryptophan [911]. Isotope tracer analysis 
demonstrated that the carbon skeleton of 13C-labeled 
L-serine is mainly converted to glycine [9]. This reaction is 
catalyzed by the gene product of glyA, a serine hydroxyme-
thyltransferase (SHMT) [12]. SHMT catalyzes the reversi-
ble, simultaneous conversion of L-serine to glycine and tet-
rahydrofolate to 5,10-methylenetetrahydrofolate. Since this 
reaction provides the majority of the C1 units needed for cell 
growth, disruption of the glyA gene is lethal to host cells [12]. 
A recent study identified that, in the stationary growth  
phase, glyA gene expression is tightly controlled by an acti- 
 
 
Figure 1  Strategy to engineer C. glutamicum for L-serine production. 
Genetic manipulation includes the inactivation of the catabolic genes sdaA 
and glyR (double short lines), the release of the feedback inhibition of 
3-phosphoglycerate dehydrogenase (PGDH) by L-serine (dotted long arrow) 
and the over-expression of the biosynthesis genes pgk and feedback-re- 
sistant serAr (boldfaced arrows). 1,3-2P-glycerate: 1,3-diphosphoglycerate; 
3P-glycerate: 3-phosphoglycerate; P-hydroxypyruvate: phosphohydroxy-
pyruvate; P-serine: phosphoserine; FH4: tetrahydrofolate and FH4=CH2:  
5,10-methylenetetrahydrofolate. 
vator GlyR at the transcriptional level [13]. This finding 
provides a possible regulatory tool to control the flux from 
L-serine to glycine by manipulating GlyR expression. 
At present, the industrial production of L-serine mainly 
depends on the enzymatic or cellular conversion of the sub-
strate glycine and a C1 compound in the presence of an en-
zyme system composed of SHMT [14]. Many metha-
nol-utilizing bacteria, such as Hyphomicrobium methylo-
vorum, have been applied to produce L-serine by using gly-
cine and methanol [15]. These systems either use expensive 
substrates or exhibit low productivity that extremely re-
stricts their application for L-serine production. In addition, 
using these industrial strains, large-scale fermentation for 
L-serine production is not achieved and unlike the produc-
tion of other amino acids, the conversion of cheap sugar to 
L-serine is very difficult. 
C. glutamicum is amenable to genetic modification and 
shows robust fermentation characteristics using glucose as a 
carbon source, hence making it a good candidate to produce 
amino acids [16,17]. Subjected to systems metabolic engi-
neering in recent years, C. glutamicum has been successfully 
applied to produce amino acids including L-lysine, L-valine 
and L-methionine [1719]. However, the L-serine produc-
tion from this bacterium is not yet suitable for industrial 
application [20], mainly due to the fact that the metabolic 
regulatory systems for intracellular L-serine accumulation 
remain largely unknown. In this study, we constructed an 
engineered strain SER-8, quantified its extra- and in-
tra-cellular products and analyzed its carbon flux redistribu-
tions by constructing elementary modes to obtain functional 
insights into the performance of metabolic networks. 
1  Materials and methods 
1.1  Bacterial strains, plasmids, and cell growth 
All bacterial strains and plasmids used in this study are 
listed in Table 1. Luria-Bertani medium was used for E. coli 
at 37°C. Brain heart infusion medium was used as a com-
plex medium for C. glutamicum at 30°C. As a minimal me-
dium, CGX medium was used with 40 g L1 glucose [24]. If 
necessary, antibiotics were added at the following concen-
trations: 100 μg mL1 ampicillin, 50 μg mL1 kanamycin or 
20 μg mL1 chloramphenicol for E. coli and 25 μg mL1 
kanamycin or 10 μg mL1 chloramphenicol for C. glutami-
cum. The strains harboring the plasmid with the Ptac pro-
moter were cultivated with the addition of 1 mmol L1 iso-
propyl-β-D-thiogalactoside (IPTG). 
1.2  Construction of plasmids and strains 
All genetic modifications were introduced into the C. glu-
tamicum genome using the homologous sacB recombination 
system [25,26]. Gene disruption was performed as de-
scribed previously [27]. Correct integration and in-frame 
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Table 1  Strains and plasmids used in this study 
Strains and plasmids Relevant characteristics Reference or source 
E. coli   
DH5α supE44, φ80 lacZ∆M15, hsdR17, recA1, endA1, 
gyrA96,thi-1,relA1 
[21] 
C. glutamicum   







SER-2 WT-∆sdaA ∆glyR This work 
SER-3 WT-∆sdaA ∆glyR serAr This work 
SER-4 SER-3/pXMJ19 This work 
SER-5 SER-3/pWYE1115 This work 
SER-6 SER-3/pWYE1116 This work 
SER-7 SER-3/pWYE1117 This work 
SER-8 SER-3/pWYE1118 This work 
Plasmids   
pK18mobsacB Kmr b), containing lacIq [22] 
















pWYE1117 pXMJ19-pgk-serAr This work 
pWYE1118 pXMJ19-serAr-pgk This work 
a) ATCC, American Type Culture Collection. b) Kmr, kanamycin resistance; Cmr, chloramphenicol resistance. 
gene deletion were verified by PCR and sequencing. The 
genes were amplified with the primers listed in Appendix 
Table 1 in the electronic version. The PCR product was 
sub-cloned into the pMD19-T vector (Takara, Japan). The 
resultant plasmid was digested with Xba I/Kpn I, and the 
pgk or serAr-containing insert was ligated into Xba I/Kpn 
I-treated pXMJ19 to construct pWYE1115 (pXMJ19-pgk) 
and pWYE1116 (pXMJ19-serAr), respectively. Considering 
the polar effect, two other plasmids harboring pgk and serAr 
in different tandem orders were constructed as follows: the 
pMD19-T-serAr-R was digested with Kpn I/EcoR I and li-
gated into pWYE1115 to construct pWYE1117 (pXMJ19- 
pgk-serAr). The pMD19-T-pgk-R was digested with Kpn I/ 
EcoR I and ligated into pWYE1116 to construct pWYE- 
1118 (pXMJ19-serAr-pgk). 
1.3  Fermentation in shake flasks and a bioreactor 
In the shake-flask growth experiment, C. glutamicum strains 
were precultured in the seed medium CGIII at 30°C and 200 
r min1 until the A600 reached 12. 1 mL of seed culture was 
inoculated in a 500-mL baffled shake flask with 30 mL 
CGX medium [24]. The cells were grown in triplicate at 
30°C and shaken at 120 r min1. The pH was maintained at 
7.07.2 by supplementation with ammonia. 
Fed-batch fermentation was carried out in a 7.5-L biore-
actor (BioFlo®/CelliGen®115, New Brunswick, USA) with 
a working volume of 2 L CGX medium containing 20 g L1 
initial glucose. After 4 h of growth, from an A600 of 0.2 to an 
A600 of 2.0, 0.8 mmol L
1 IPTG was added for induction of 
Ptac. The feed started after the residual sugar concentration 
was <10 g L1 with feed medium containing 400 g L1 glu-
cose. Temperature was maintained at 30°C using cooling 
water circulation. The pH was maintained at 7.2 by auto-
mated addition of ammonia and 100 mmol L1 H3PO4. Dis-
solved oxygen was determined using a pO2 electrode and 
maintained above 30% saturation level by variation of the 
stirrer speed. 
1.4  Determination of intracellular metabolites—sam- 
pling, quenching, and extraction 
Bioreactor-grown cells were harvested at mid-exponential 
growth phase. 5 mL of culture was injected into the 
quenching solutions (60% aqueous methanol+70 mmol L1 
Hepes) and directly centrifuged at 5200×g at –20°C. After 
the removal of the supernatant, cell pellets were immedi-
ately frozen at –80°C [28,29]. Subsequently, cell pellets 
were extracted three times by boiling at 90°C for 5 min as 
described previously [30]. The obtained extracts were 
evaporated to dryness in a pump under vacuum at room 
temperature. After suspension of the extracts in 500 μL of 
water, cell debris was removed by centrifugation for 10 min 
at 5500×g. After decanting, the supernatant was stored at 
–80°C until further analysis [29]. To reduce variations in 
feeding and maintain accuracy, SER-0 and SER-8 were 
grown in CGX minimal medium with 40 g L1 glucose in a 
batch-fermentation process. 
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1.5  Analytical methods 
The glucose concentration was measured using an SBA- 
40D biosensor analyzer (Institute of Biology of Shandong 
Province Academy of Sciences, Shandong, China). Cell dry 
mass (CDM) was estimated with a spectrophotometer (1.0 
A600 is equivalent to 0.27 g L
1 CDM). Amino acids in the 
culture supernatant were determined using high perfor-
mance liquid chromatography with a Zorbax Eclipse 
XDB-C18 column (4.6 mm×250 mm, 5 μm; Agilent) at 
40°C after derivatization with 2,4-dinitrofluorobenzene. 
Mobile phase A was 55% (v/v) acetonitrile whereas mobile 
phase D consisted of 40 mmol L1 KH2PO4 at pH 7.07.2. 
The flow rate of the mobile phase was 1 mL min1. 
1.6  Elementary mode and metabolic flux analysis 
The C. glutamicum metabolic network was constructed as 
shown in Figure 3. The model was based on utilizing glu-
cose as the carbon source. The complete set of reactions 
used for the elementary mode analysis is listed in Appendix 
Table 2 in the electronic version. The pathway details were 
collected from the KEGG database (http://www.kegg.com), 
comprising reactions involved in the glycolysis pathway 
(EMP), the pentose phosphate pathway (PPP), the tricar-
boxylic acid cycle (TCA), anaplerotic reaction converting 
phosphoenol pyruvate (PEP) into oxaloacetic acid (OAA) 
and synthetic reactions for serine, glycine, pyruvate, alanine, 
valine, isoleucine, leucine, glutamine, lysine, succinic acid 
and histidine. Intracellular fluxes were estimated from 
measurements of metabolite uptake and output rates (ex-
change fluxes) by a pseudo-steady-state approximation 
[31,32]. Elementary mode analysis was constructed using 
MATLAB software version 7.0 (MathWorks). Stoichio-
metric coefficients of the external metabolites present in  
the modes were written in the form of a matrix equation  
(eq. (1)):  
 Ax(t)=r(t), (1) 
where A is an m×n matrix of stoichiometric coefficients, the 
number of rows was equal to the number of external metab-
olites and the number of columns was equal to the number 
of modes [32]. 
The stoichiometric model in this study (Appendix Tables 
2 and 3 in the electronic version) consists of 29 reactions 
and 17 compounds; the degree of freedom (DF) is 2917=12, 
which means that changes in the rate of twelve compounds 
should be measured to determine all of the reaction rates  
in the metabolic network. External metabolites considered 
to generate flux distribution maps during the course of  
the fermentation were measured for quantification, in-
cluding glucose, serine, glycine, alanine, valine, isoleucine,   
leucine, glutamine, lysine, succinic acid, histidine and 
biomass. 
2  Results 
2.1  Metabolic engineering of C. glutamicum for serine 
production 
Our overall strategy to optimize C. glutamicum for L-serine 
production was to simultaneously enhance its biosynthesis 
and reduce its degradation (Figure 1; also see introduction 
section). For the latter, an sdaA-null strain, SER-1, was first 
created to block the degradation of L-serine to yield py-
ruvate. The glyR gene was deleted subsequently in SER-1 to 
create the sdaA- and glyR-double-null mutant, SER-2. 
SER-2 lacks the transcriptional activator GlyR to up-regu- 
late the SHMT expression in the stationary phase and is 
supposed to reduce the conversion of L-serine to glycine. In 
order to enhance the L-serine biosynthesis, strain SER-3 
was created from SER-2 to have the endogenous PGDH 
replaced with a C-terminal 197 amino acid truncated one. 
Based on SER-3, three further steps were applied to in-
crease the supply of the key precursor substrate for L-serine 
biosynthesis, 3-phosphoglycerate, by over-expressing either 
PGK (SER-5) or the feedback-resistant PGDH variant 
(PGDHr) (SER-6). Following this strategy, a series of mu-
tant strains were generated to facilitate the metabolic dis-
section of the contribution of these individual enzymes to 
L-serine accumulation. This design also made the analysis 
of the effects of these gene modifications on the metabolism 
of C. glutamicum possible (Figure 1). 
2.2  Metabolic analysis of the mutant strains for 
L-serine production 
Use of both the SER-1 and SER-2 strains did not improve 
the L-serine production, indicating that blocking the degra-
dation of L-serine to pyruvate and reducing the conversion 
of L-serine to glycine hardly contributed to L-serine accu-
mulation. Strain SER-3 can accumulate L-serine at a level of 
0.01 mmol L1, suggesting that the rate-limiting enzyme, 
PGDH, might be a minor metabolic node for L-serine ac-
cumulation in C. glutamicum and further improvement of 
the metabolic flux toward L-serine biosynthesis was neces-
sary. Strain SER-3 was engineered to harbor plasmid-based 
pgk (SER-5) or feedback-resistant serAr (SER-6). Use of 
these two strains further increased L-serine accumulation, 
suggesting that increasing the supply of precursors contrib-
uted to L-serine biosynthesis. Then, pgk and serAr were 
co-expressed in strain SER-3. The resulting strain, SER-8, 
showed a significant increase in L-serine accumulation, 
reaching a maximal level of (0.425±0.019) mmol L1 during 
early fermentation after 9 h of cultivation, a 14.16-fold in-
crease over the control strain SER-4 in shake flasks. 
2.3  Physiological evaluation of SER-8 on an increased 
scale 
2.3.1  The fermentation of SER-8 in a 7.5-L bioreactor 
In order to assess the overall consequences of these five 
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genetic modifications on strain growth and L-serine produc-
tion, a fed-batch fermentation in glucose minimal medium 
was performed in a 7.5-L bioreactor. As shown in Figure 
2A, the fermentation process exhibited five distinct phases: 
Phase I, pure growth (0–15 h); Phase II, transition from pure 
growth to L-serine production (15–22 h); Phase III, L-serine 
accumulation at the expense of growth (22–28 h); Phase IV, 
L-serine productivity loss and a small degree of restoration 
of growth (28–37 h); and Phase V, death and L-serine yield 
stability (37–60 h). The specific growth of strain SER-8 was 
0.26 h1, significantly lower than that of the control strain, 
SER-0 (μmax=0.49 h1). The maximal CDM reached 16.71 g  
 
 
Figure 2  Physiological variation of SER-8 in a 7.5-L bioreactor. A, Per-
formance of strain SER-8 in a fed-batch fermentation on CGX minimal 
medium with 20 g L1 glucose showing growth, the accumulation of extra-
cellular L-serine and glycine. B, Variations of intracellular L-serine and 
glycine levels depending on the incubation period in the medium. C, Intra-
cellular pools of L-serine and glycine in mid-exponential phase; to reduce 
variation of feeding glucose, SER-0 and SER-8 were grown in CGX mini-
mal medium containing 40 g L1 glucose in a batch-fermentation. Error  
bars show the standard deviation for triple biological samples. 
L1 after 22 h of cultivation and the maximal L-serine pro-
duction reached 1.21 mmol L1 after 28 h. 
2.3.2  The extra- and intra-cellular variation of L-serine 
and glycine 
Extracellular L-serine reached a maximum at 28 h and then 
decreased until the end of the fermentation. The extracellu-
lar glycine accumulated at the beginning of cultivation and 
reached as high as 2.24 mmol L1. After that, the glycine 
level kept increasing slightly along with the utilization of 
L-serine even after completion of Phase IV. For all ferment-
ative phases, the extracellular L-serine level was much low-
er than glycine (Figure 2A). On the other hand, the intra-
cellular L-serine level reached a maximum of 10.56 μmol 
gCDM
1 after about 15 h of cultivation prior to its excretion 
(Figure 2B) and declined afterwards. On the contrary, the 
intracellular glycine was significant lower than the intracel-
lular L-serine and increased continuously during the whole 
fermentation process (Figure 2B).  
2.3.3  The intracellular pool of L-serine and glycine 
A comparison of the intracellular pool of L-serine and gly-
cine from SER-8 to that of SER-0 indicated that an 
8.08-fold increase was achieved, i.e., from (1.76±0.11) to 
(14.22±1.41) μmol gCDM1 while the glycine pool increased 
by 34%, from (4.65±0.47) to (7.35±1.35) μmol gCDM1 
(Figure 2C). The increased intracellular pool of both 
L-serine and glycine in SER-8 indicated that a higher flux 
was indeed directed into the L-serine biosynthesis pathway 
in the desired manner as designed. Interestingly, it was also 
noticed that the intracellular L-serine pool was much lower 
than glycine in SER-0 (Figure 2C). In contrast, SER-8 
showed a higher intracellular pool of L-serine than glycine. 
2.4  Comparative metabolic flux analysis of strains 
SER-0 and SER-8 
To compare the flux distribution of the glycolysis pathway 
(EMP), the pentose phosphate pathway (PPP), the TCA 
cycle and the L-serine metabolism pathway in SER-0 and 
SER-8, the relative fluxes of the metabolic pathway were 
normalized to the glucose uptake rate (%) as shown in Fig-
ure 3. Significant changes in the flux distribution of EMP 
and PPP were observed between the SER-0 and SER-8 
strains. The ratio of EMP flux in strain SER-8 significantly 
increased, implying the over-expression of PGK redirected 
more flux from PPP toward EMP. As a result of the in-
creased EMP, SER-8 exhibited an almost 27% increase of 
the relative flux through the TCA cycle. Despite the fact 
that the supply of 3-phosphoglycerate increased, only a rel-
atively small flux (0.68%) was assigned to the L-serine bio-
synthesis pathway. The flux toward L-serine biosynthesis 
was elevated to 2 fold, indicating the over-expression of 
PGDHr redirected more flux to the L-serine biosynthesis 
pathway. In addition, the flux from L-serine to glycine  
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Figure 3  In vivo carbon flux distribution in the central metabolism of the control strain SER-0 (upper numbers of each pair) and the mutant SER-8 (lower 
numbers of each pair) during growth on glucose. All fluxes are expressed as the molar percentage of the mean specific glucose uptake rate (2.47 mmol g1 
h1 for the control strain SER-0, 1.58 mmol g1 h1 for the mutant SER-8), which is defined as 100%. A replicate batch experiment showed consistent results  
with a standard deviation of 10%. 
dropped by 24%, suggesting the conversion of L-serine to 
glycine was reduced by deleting the activator GlyR to 
down-regulate SHMT at the transcriptional level. Further-
more, the extracellular L-serine shunt flux increased to 
0.43% in strain SER-8. In contrast, the total L-serine in 
strain SER-0 was utilized for the generation of glycine, re-
sulting in no net L-serine outside the cell for SER-0. 
3  Discussion 
In this study, a systematical investigation was performed on 
C. glutamicum to determine the effects of different genetic 
modifications on L-serine production. The mutant SER-8, a 
combination of five modified genes in C. glutamicum, ex-
hibited a higher L-serine production (Figure 2A). According 
to the changes in flux distribution between strain SER-8 and 
SER-0 (control strain), over-expressing PGK can “push” 
carbon flux into the G3P pool, whereas engineering of 
PGDHr can “pull” the carbon flux from the G3P pool into 
the L-serine biosynthesis pathway. This demonstrates that 
increases of the supply precursors are responsible for im-
proving the flux distribution in L-serine biosynthesis. 
The conversion of L-serine to glycine is the main degra-
dation pathway of L-serine in C. glutamicum. It is impossi-
ble to disrupt the glyA gene since this reaction provides the 
majority of the C1 units for cell growth [12]. When the ex-
pression of the glyA gene was controlled under the Ptac 
promoter, L-serine accumulation was obviously increased in 
the absence of IPTG and simultaneously the growth of cells 
was seriously reduced [20]. Nevertheless, strong inhibition 
of glyA expression resulted in apparent instability of the 
engineered strain [16]. Our results showed that despite the 
deletion of the activator GlyR was believed to be responsi-
ble for decreasing the conversion of L-serine to glycine to a 
certain degree, the ratio of flux toward glycine was still 
38.2%. It further demonstrated that the conversion of 
L-serine to glycine is a rate-limiting step for L-serine accu-
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mulation. Therefore, controlling the glyA expression under a 
promoter of relatively weak activity would further reduce 
the conversion of L-serine to glycine.  
L-Serine synthesis and accumulation was probably in-
duced by growth limitation in these strains. This notion was 
supported by the observation of the decreases in the specific 
growth rate and biomass yield. The genetic modifications in 
C. glutamicum had a significant impact on the maximum 
growth rate (μmax) in accordance with previous reports [20]. 
Amino acid production under conditions of general growth 
limitations has been described elsewhere [18,33]. The de-
crease of the specific growth rate reflected a redirection of 
carbon flux due to genetic modifications of the L-serine 
biosynthetic pathway toward anabolic routes, and the 
co-metabolism of L-serine with glucose has shown that a 
distinct metabolic switch occurs—from the stage of incor-
poration of L-serine into biomass [9]. The growth mainte-
nance during the stationary phase partially occurred at the 
expense of L-serine, which was evident from the gradual 
decrease in the concentration of L-serine and a concomitant 
sharp increase of glycine (Figures 2A and B). The positive 
effect of the genetic modifications on L-serine formation 
was diminished by simultaneous reutilization of L-serine to 
sustain physiological fitness. This suggests that L-serine 
biosynthesis occurred mainly at the expense of growth, and 
it would be optimal to decrease the specific growth rate for 
L-serine accumulation. Taken together, our findings imply 
that L-serine pool management was well correlated with the 
viability of C. glutamicum. 
Interestingly, extracellular glycine continuously accu-
mulated during all fermentative phases. For E. coli, the gly-
cine cleavage (GCV) system converts glycine to 
5,10-methylenetetrahydrofolate [34]. This system plays an 
important role in maintaining the intracellular homeostatic 
balance between glycine and concentrations of C1 units [34]. 
However, glycine is an end-product without an efficient 
supply as a direct precursor in C. glutamicum [35]. There-
fore, the export of redundant glycine might be an alternative 
way for C. glutamicum to maintain an intracellular glycine 
metabolic equilibrium. These findings make it possible to 
consume the intracellular redundant glycine by integrating 
the GCV system of E. coli into the C. glutamicum chromo-
some. In this way, the GCV system will generate more ac-
tive C1 units to provide a balance between cell growth and 
L-serine accumulation in C. glutamicum. Therefore, im-
proving the generation of C1 units by introducing the GCV 
system to degrade the excessive glycine is a promising tar-
get for the metabolic engineering of C. glutamicum for 
L-serine production. 
In this study, several systems metabolic engineering 
strategies have been attempted to develop a L-serine pro-
duction strain. Since the entire metabolic and regulatory 
networks are woven into a global system in an integrated 
manner, some target gene engineering is still necessary until 
an optimal strategy is obtained [36,37]. The work reported 
herein provides a framework of information on the direct 
fermentative production of L-serine from glucose. 
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